12th Annual IBA World Life Sciences Conference

3 Jun - 5 Jun 2026

Session information

Hot topic roundtables

Description

  1. Collaboration and licensing structures as financing tools 
  2. The new frontiers of telemedicine
  3. Cross-border investment constraints affecting financings and exits (CFIUS risk, sensitive health/genomic data, and closing conditions)
  4. Cooperations between and vertical integration of pharma/medtech and hospitals/clinics/pharmacies etc [SF1.1]
  5. GLP‑1s: are legal frameworks keeping pace with the weight‑loss revolution? 
  6. Resolving international patent licensing disputes by arbitration – recurring issues and new developments
  7. Liability and accountability in open science research
  8. The future of supplementary protection: are SPCs still fit for purpose? 
  9. Advertising, labelling and influencer promotion of medicinal products 
  10. Combination products (drug-device) regulation
  11. Causes and consequences of ‘medical device and drugs lag’
  12. Whistleblower actions and anti-fraud enforcement trends in the healthcare industry 
  13. When pharmaceutical patent enforcement leads to damages – for either side
  14. Pricing of medicines: an international perspective 
  15. Ethical and legal challenges of human genome editing

Speakers

Andrea Abascal Bofill Mir Abogados, Santiago, Chile; Conference Quality Officer, Healthcare and Life Sciences Law Committee
Joana Botelho Cuatrecasas, Lisbon, Portugal
Gustaf Duhs Stevens & Bolton, Guildford, England
Jordi Faus Faus & Moliner Abogados SLP, Barcelona, Spain
Francisco Javier García Pérez Uria Menendez, Barcelona, Spain
Monika Gattiker DGS Rechtsanwälte Steuerexperten, Zürich, Switzerland; Treasurer, Healthcare and Life Sciences Law Committee
Philipp Groz Schellenberg Wittmer, Zürich, Switzerland
Tímea Halkó Gedeon Richter, Budapest, Hungary
Yuval Horn Gornitzky & Co, Tel Aviv, Israel; Member, Technology Law Committee Advisory Board
Joanna Krakowiak Wardynski & Partners, Warsaw, Poland
Jose Alejandro Luna Fandino Olivares, Mexico City, Mexico
Sir Guilherme Mendonça Coloplast, São Paulo, Brazil
Hugo Monteiro de Queirós PLMJ, Lisbon, Portugal
Jackie Mulryne Morgan Lewis, London, England
Sean Murray Knobbe Martens Olson and Bear LLP, Irvine, California, USA
Ricardo Nascimento Ferreira Morais Leitão, Lisbon, Portugal
Matthias Nordmann SKW Schwarz , Munich, Germany
Adeniji Oni Niji Oni & Co, Lagos, Nigeria; Senior Vice Chair, Agriculture and Food Section
Francisca Paulouro VdA Vieira de Almeida, Lisbon, Portugal
Leonor Pissarra SRS Legal, Lisbon, Portugal
Elysangela Rabelo Demarest Advogados, São Paulo, Brazil; Chair, Life Sciences Subcommittee
Ioana Ratescu Novartis Pharma AG, Basel, Switzerland
Janine Reudt-Demont Niederer Kraft Frey AG, Zürich, Switzerland; Social Media and Website Officer, Healthcare and Life Sciences Law Committee
Anderson Ribeiro Souto Correa Advogados, São Paulo, Brazil; Scholarship Officer, Healthcare and Life Sciences Law Committee
Markus Schott Baer & Karrer, Zürich, Switzerland; Vice Chair, Healthcare and Life Sciences Law Committee
Christopher Stovin Incyte Biosciences, Lausanne, Switzerland
Koen T'Syen Van Bael & Bellis, Brussels, Belgium
Lincoln Tsang Ropes & Gray LLP, London, England
Tess Waldron Powell Gilbert LLP, London, England
Conna Weiner Conna Weiner ADR, Boston, Massachusetts, USA
Milena Yakimova Baxter International , Sofia, Bulgaria